For pharma, volatility and value are two sides of the same coin
But beyond output consistency, a diversified manufacturing base is important: EDB
Singapore
FOR the four months to July, Singapore's export-oriented drug industry notched up double-digit yearly growth, while July exports surged a stunning 109 per cent - yet industry players are hard put to forecast a consistent trajectory.
Rather, the prognosis for the notoriously volatile sector is for it to hold "steady".
TRENDING NOW
Britain’s mansion tax shows the difficulty of targeting wealth
Once staunchly pro-China, Malaysian Chinese businesses are now distancing themselves from Beijing
The only common thing in S-E Asia is that we all eat rice: Cisco’s Asean president
Singapore data centre operator DayOne opts for US IPO at likely US$20 billion valuation
